Monday 1st December – Day 1 Main Conference - GMT (Greenwich Mean Time, GMTZ)
Starting from a brownfield and a greenfield, 2 brand new facilities for CAR-T production were built in Ghent in 2-3 years’ time. Building up the facility, recruiting and training people, building and qualifying processes and systems, passing HA inspections, meeting customer’s needs, an amazing experience for all involved.
- Snapshot into the investment landscape for CGT products and enabling technologies: Our expert investors reveal their bold predictions for CGT's trajectory through 2026
- Uncover game-changing investment opportunities in CGT as leading investors reveal which technologies are poised to disrupt healthcare and deliver exceptional returns
- Standing out in the crowd: Positioning for success in a competitive funding environment: What do investors need to see?
“Ask the Investor” interactive Q&A open discussion with our investor panel to get tips and tricks when pitching and their views on where innovation lies in the CGT field
- Bo Wiinberg - Chief Business Development Officer, Novo Nordisk Foundation Cellerator
- Artemy Shumskiy - Principal, LongeVC
Visit BioLife Solutions during the Live Lab tour. BioLife Solutions is a leading developer and supplier of cell processing tools and services for the cell and gene therapy market. Our expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, manufacturing and distribution. During this presentation, we will discuss impact of cell culture ancillary materials on cell health and performance, highlight downstream fill/finish and primary packaging considerations as well as present some information around optimisation of biopreservation.
Join the Terumo Blood and Cell Technologies Live Lab session and discover how the Quantum Flex™ Cell Expansion System can help you simplify, de-risk, and accelerate your cell expansion journey—from process development through to commercial manufacturing.
Visit KyooBe during the Live Lab tour and explore our innovative cube-based production approach for cell and gene therapies. Our cubes are mobile aseptic units that integrate seamlessly with isolators for safe, segregated batch production. Experience how closed modular design and automation bring flexibility, safety, and efficiency to personalized medicine.
Explore groundbreaking research, meet the poster presenters and ask your questions.